A correlação dos níveis de colesterol e doenças cardiovasculares em idosos

Authors

  • Iara Guimarães Rodrigues
  • Débora Vieira
  • Ana Júlia Moreira Vilaça
  • Cecilia Cristina Machado Borges
  • Fabio Vecchini Martins
  • Isadora Carpim Oliveira
  • Kamilla Teresa Sousa Silva IMEPAC
  • Livian Ferreira Paneago

DOI:

https://doi.org/10.47224/revistamaster.v8i15.359

Keywords:

Doenças cardiovasculares, colesterol, lipoproteína de baixa densidade (LDL)

Abstract

Introduction: The increase in cholesterol concentration, primarily low-density lipoprotein (LDL), is considered a potential risk for cardiovascular disease. Objective: This article aims to analyze the correlation between levels of lipoprotein cholesterol (low density) and cardiovascular events in the elderly population. Methods: Consists of an integrative literature review of published studies and indexed in the PubMed platform database, in which the inclusion criteria were articles available from the year 2018, free of charge, in English and Portuguese, and that addressed the theme of correlation between the risk of cardiovascular disease and cholesterol levels. Results and Discussion: Although some previous studies have demonstrated a relationship of up to 50% between hypercholesterolemia at the expense of LDL and coronary events, only one of the five studies analyzed demonstrated this association. The others, however, ruled out the possibility that high levels of LDL cholesterol lead to cardiovascular events in the elderly, such as coronary heart disease, heart failure and death from cardiac causes. This is related to several factors, the characteristics of cholesterol, the concentration in the vessel, as well as other morbidities that alter the vascular characteristics.  Conclusion: Other facts should be considered in the cardiovascular outcomes of the elderly, since hypercholesterolemia alone is not a risk predictor alone. 

Downloads

Download data is not yet available.

References

AVEZUM, A.; PIEGAS, L. S; PEREIRA, J. C. R. Fatores de risco associados com infarto agudo do miocárdio na região metropolitana de São Paulo: uma região desenvolvida em um país em desenvolvimento. Arquivos Brasileiros de Cardiologia, v. 84, p. 206-213, 2005. DOI: https://doi.org/10.1590/S0066-782X2005000300003

BUDDE, T. et al. Plasma Lp (a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, v. 14, n. 11, p. 1730-1736, 1994. DOI: https://doi.org/10.1161/01.ATV.14.11.1730

CHARACH, G. et al. Usefulness of Antibodies to Oxidized Low-Density Lipoproteins as Predictors of Morbidity and Prognosis in Heart Failure Patients Aged≥ 65 Years. The American Journal of Cardiology, v. 116, n. 9, p. 1379-1384, 2015. DOI: https://doi.org/10.1016/j.amjcard.2015.07.053

CHARACH, G; ARGOV, O; NOCHOMOVITZ, H et al. A longitudinal 20 years of follow up showed a decrease in the survival of heart failure patients who maintained low LDL cholesterol levels. QJM: An International Journal of Medicine, v. 111, n. 5, p. 319–325, 2018. DOI: https://doi.org/10.1093/qjmed/hcy043

Doenças cardiovasculares: principal causa de morte no mundo pode ser prevenida. Gov.br, 2022. Disponível em https://www.gov.br/pt-br/noticias/saude-e-vigilancia-sanitaria/2022/09/doencas-cardiovasculares-principal-causa-de-morte-no-mundo-pode-ser-prevenida#:~:text=Doen%C3%A7as%20cardiovasculares%3A%20principal%20causa%20de%20morte%20no%20mundo%20pode%20ser%20prevenida,-Sistema%20%C3%9Anico%20de&text=As%20doen%C3%A7as%20cardiovasculares%20s%C3%A3o%20a,mas%20em%20todo%20o%20mundo Acesso em 9 de novembro de 2022.

Estatísticas de Saúde da OCDE 2022. OCDE, 2022. Disponível em < Estatísticas de Saúde da OCDE 2022 - OCDE (oecd.org)> Acesso em 8 de novembro de 2022.

HIGASHIOKA, M.; SAKATA, S.; HONDA, T. et al. Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community. Journal of Atherosclerosis and Thrombosis, v. 27, n. 7, p. 669–682, 2020. DOI: https://doi.org/10.5551/jat.51961

Izar M, et al. Manejo do risco cardiovascular: dislipidemia. Diretriz Oficial da Sociedade Brasileira de Diabetes (2022). DOI: 10.29327/557753.2022-19, ISBN: 978-65-5941-622-6. DOI: https://doi.org/10.29327/557753.2022-19

KIM, S.H; SON, K.Y. Association between lipoprotein cholesterol and future cardiovascular disease and mortality in older adults: a Korean nationwide longitudinal study. Lipids in Health and Disease, v. 20, n. 1, 2021. DOI: https://doi.org/10.1186/s12944-020-01426-0

LIMA, L.M; CARVALHO, M.G; SOUSA, M.O. Correlações entre lipoproteínas e apolipoproteínas na doença arterial coronariana. Rev Med Minas Gerais, v. 21, n. 3, p. 260-265, 2011.

LIOU, L.; KAPTOGE, S. Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis. PLOS ONE, v. 15, n. 11, p. e0241993, 2020. DOI: https://doi.org/10.1371/journal.pone.0241993

MARTINELLI, A.E.M. Papel dos lípides plasmáticos e fatores pró-inflamatórios na fisiopatologia da insuficiência cardíaca. 2017. Tese de Doutorado. Universidade de São Paulo.

MENDES, K.D.S; SILVEIRA, R.C.C; GALVÃO, C.M. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto - Enfermagem, [S.L.], v. 17, n. 4, p. 758-764,2008. DOI: https://doi.org/10.1590/S0104-07072008000400018

NANNA, M.G et al. The Association Between Low‐Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts. Journal of the American Geriatrics Society, v. 67, n. 12, p. 2560–2567, 2019. DOI: https://doi.org/10.1111/jgs.16123

OMS revela principais causas de morte e incapacidade em todo o mundo entre 2000 e 2019. OPAS, 2020. Disponível em < https://www.paho.org/pt/noticias/9-12-2020-oms-revela-principais-causas-morte-e-incapacidade-em-todo-mundo-entre-2000-e> Acesso em 10 de novembro de 2022.

ONAT, A. et al. Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks/Turk halkinda yeni gelisen koroner hastalik ongordurucusu olarak serum apolipoprotein B duzeyi LDL-kolesterolden ustun. The Anatolian Journal of Cardiology (Anadolu Kardiyoloji Dergisi), v. 7, n. 2, p. 128-134, 2007.

SAMPSON, R.U; FAZIO, S.; LINTON, M.F. Risco Cardiovascular Residual Apesar da ótima redução do colesterol LDL com estatinas: as evidências, etiologia e desafios terapêuticos. Curr Atheroscler, v.14, p.1-10, 2012. DOI: https://doi.org/10.1007/s11883-011-0219-7

SHAH, T.; SWERDLOW, D. Detecting, predicting and modifying cardiovascular risk: new and developing strategies. Expert Review of Cardiovascular Therapy, v. 8, n. 11, p. 1519-1521, 2010. DOI: https://doi.org/10.1586/erc.10.132

Published

2023-07-14

How to Cite

GUIMARÃES RODRIGUES, I. .; VIEIRA , D. .; MOREIRA VILAÇA , A. J. .; MACHADO BORGES , C. C. .; VECCHINI MARTINS , F. .; CARPIM OLIVEIRA , I. .; SOUSA SILVA, K. T.; FERREIRA PANEAGO , L. . A correlação dos níveis de colesterol e doenças cardiovasculares em idosos. Revista Master - Ensino, Pesquisa e Extensão, [S. l.], v. 8, n. 15, 2023. DOI: 10.47224/revistamaster.v8i15.359. Disponível em: https://revistamaster.emnuvens.com.br/RM/article/view/359. Acesso em: 21 nov. 2024.

Most read articles by the same author(s)

1 2 > >>